Management of Elevated INR in Cannulation Procedures

Introduction to INR Management

The American College of Cardiology recommends that elevated INR should not be considered a contraindication to central venous cannulation, as the risk of bleeding complications can be managed with appropriate technique and precautions 1
The risk of bleeding complications increases exponentially with rising INR levels, with a 2.7-fold increase in major hemorrhage risk when INR rises from 2.0-3.0 to 3.0-5.0 1

For INR 1.5-3.0, proceed with cannulation using standard technique and apply prolonged manual compression (5-10 minutes minimum) after needle withdrawal, using the smallest gauge needle feasible 1
For INR 3.0-5.0, cannulation can proceed if clinically necessary, with firm pressure for 10-15 minutes minimum after procedure and consideration of ultrasound guidance to minimize multiple needle passes 1
For INR >5.0, withhold warfarin and recheck INR in 24 hours before proceeding if non-urgent, or proceed with cannulation but anticipate prolonged compression times and higher bleeding risk if urgent 1, 2
For INR >10.0, immediate reversal is required before elective procedures, with options including fresh frozen plasma or prothrombin complex concentrate, and vitamin K 2.5-5 mg orally or 5-10 mg IV for patients without or with active bleeding, respectively 1

The American Heart Association advises against delaying necessary cannulation solely based on elevated INR in the therapeutic range (2.0-3.0), as this can be done safely with appropriate technique 2
The European Society of Cardiology recommends against assuming INR >3.5 is safe for procedures, as the risk of intracranial bleeding increases particularly when INR exceeds 3.5, and elderly patients exhibit greater bleeding risk at these levels 2, 3
The American College of Chest Physicians advises against giving high-dose vitamin K routinely for moderately elevated INR, as this may create a hypercoagulable condition and make re-anticoagulation difficult 4